Antiplatelet activity of obovatol, a biphenolic component of Magnolia obovata, in rat arterial thrombosis and rabbit platelet aggregation = 오보바톨의 항혈전 활성 및 기전 규명

Cited 21 time in scopus
Metadata Downloads
Title
Antiplatelet activity of obovatol, a biphenolic component of Magnolia obovata, in rat arterial thrombosis and rabbit platelet aggregation = 오보바톨의 항혈전 활성 및 기전 규명
Author(s)
E S Park; Y Lim; S H Lee; Byoung-Mog Kwon; H S Yoo; J T Hong; Y P Yun
Bibliographic Citation
Journal of Atherosclerosis and Thrombosis, vol. 18, no. 8, pp. 659-669
Publication Year
2011
Abstract
Aim: Thrombosis occurs in the coronary arteries via the activation of platelets, and leads to acute myocardial infarction and sudden death. Obovatol, a major biphenolic component of Magnolia obovata leaves, displays anti-inflammatory and acyl Co-A cholesterol acyltrasferase inhibitory effects. The purpose of this study was to determine the effects of obovatol on thrombus formation in vivo and platelet activation in vitro and ex vivo.Methods: We investigated the antiplatelet and antithrombotic activities of obovatol in rat carotid arterial thrombosis in vivo along with platelet aggregation in vitro and ex vivo. Its possible cellular mechanism of antiplatelet activity was nvestigated by testing PLC-γ2 activation, arachidonic acid cascade, calcium mobilization and granule secretion.Results: Oral administration of obovatol prevented carotid thrombosis, but also significantly inhibited collagen-induced platelet aggregation. Obovatol did not change coagulation times, such as activated partial thromboplastin time and prothrombin time, indicating that the antithrombotic effect of obovatol might be due to antiplatelet activity rather than anticoagulation activity. Obovatol inhibited in vitro collagen- and arachidonic acid-induced rabbit platelet aggregation in a concentration-dependent manner (1-10μM), with IC50 values of 2.4 ±0.8 and 4.8 ±0.9 μM, respectively. Obovatol blocked collagen-mediated phospholipase C-γ2 phosphorylation, cytoplasmic calcium mobilization, arachidonic acid liberation and serotonin secretion.Conclusion: Obovatol has a potent antithrombotic effect, which may be due to antiplatelet activity. The antiplatelet activity of obovatol is mediated by inhibition of PLC-γ2 phosphorylation. Thus, obovatol may be a potential candidate to treat cardiovascular disease.
Keyword
Antiplatelet activityFeCl3-induced thrombosis modelObovatolPLC-γ2Thrombosis
ISSN
1340-3478
Publisher
Japan Atherosclerosis Soc
DOI
http://dx.doi.org/10.5551/jat.7427
Type
Article
Appears in Collections:
1. Journal Articles > Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.